18.12.2008Wyeth Pharmaceuticals acquires Thiakis in a transaction worth up to £100m

Advent Venture Partners announces successful exit from portfolio company Thiakis in a transaction worth up to £100 million.

Press Release
21.11.2008Infinity Pharmaceuticals strikes major alliance to fully fund promising pipeline

Press Release
23.09.2008Pathworks Diagnostics closes $20m Financing

Press Release
28.08.2008Algeta Reports Positive Headline Phase II Data on Pain Palliation with Alpharadin

Press Release
14.08.2008SEP, the specialty urology company, closes a $15M series B financing

Press Release
12.03.2008Novel therapy for treatment of obesity enters clinical trials

Press Release
11.03.2008EUSA Pharma to Acquire US Specialty Oncology Company Cytogen

Press Release
25.02.2008Speciality European Pharma launches Plenaxis in Germany

Press Release
21.02.2008Algeta receives IND Approval for Alpharadin(TM) to commence Clinical Development in the USA

Press Release
18.02.2008EUSA Pharma out-licenses Preclinical-stage Human Antibody to GlaxoSmithKline for up to $44 million plus Royalities

Press Release